Insider Transactions in Q4 2020 at Neogenomics Inc (NEO)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2020
|
Lawrence Martin Weiss Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,200
-16.73%
|
$1,030,200
$51.06 P/Share
|
|
Dec 14
2020
|
Lawrence Martin Weiss Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
109,004
+19.33%
|
$1,199,044
$11.39 P/Share
|
|
Dec 14
2020
|
Steven C Jones Director |
SELL
Open market or private sale
|
Indirect |
25,000
-2.44%
|
$1,275,000
$51.67 P/Share
|
|
Dec 11
2020
|
Steven C Jones Director |
SELL
Open market or private sale
|
Indirect |
25,000
-2.38%
|
$1,250,000
$50.52 P/Share
|
|
Dec 11
2020
|
Jennifer Balliet VP and Chief Culture Officer |
SELL
Open market or private sale
|
Direct |
15,000
-37.52%
|
$735,000
$49.99 P/Share
|
|
Dec 11
2020
|
Jennifer Balliet VP and Chief Culture Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+27.28%
|
$120,000
$8.03 P/Share
|
|
Dec 10
2020
|
Steven C Jones Director |
SELL
Open market or private sale
|
Indirect |
20,000
-1.87%
|
$1,000,000
$50.3 P/Share
|
|
Dec 07
2020
|
Steven C Jones Director |
SELL
Open market or private sale
|
Indirect |
45,658
-4.09%
|
$2,237,242
$49.45 P/Share
|
|
Dec 04
2020
|
Kevin C Johnson Director |
SELL
Open market or private sale
|
Direct |
24,683
-44.34%
|
$1,160,101
$47.88 P/Share
|
|
Dec 04
2020
|
Steven C Jones Director |
SELL
Open market or private sale
|
Indirect |
64,394
-5.46%
|
$3,090,912
$48.07 P/Share
|
|
Dec 03
2020
|
Steven C Jones Director |
SELL
Open market or private sale
|
Indirect |
19,948
-1.66%
|
$957,504
$48.03 P/Share
|
|
Dec 02
2020
|
William Bonello Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,000
-39.88%
|
$368,000
$46.8 P/Share
|
|
Dec 02
2020
|
William Bonello Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+28.51%
|
$64,000
$8.03 P/Share
|
|
Nov 25
2020
|
George Cardoza President & COO, Lab Ops |
SELL
Open market or private sale
|
Direct |
77,074
-17.2%
|
$3,468,330
$45.48 P/Share
|
|
Nov 25
2020
|
George Cardoza President & COO, Lab Ops |
BUY
Exercise of conversion of derivative security
|
Direct |
77,074
+14.68%
|
$539,518
$7.52 P/Share
|
|
Nov 24
2020
|
George Cardoza President & COO, Lab Ops |
SELL
Open market or private sale
|
Direct |
52,926
-12.49%
|
$2,381,670
$45.19 P/Share
|
|
Nov 24
2020
|
George Cardoza President & COO, Lab Ops |
BUY
Exercise of conversion of derivative security
|
Direct |
72,926
+14.68%
|
$510,482
$7.52 P/Share
|
|
Nov 16
2020
|
Raymond R Hipp Director |
SELL
Open market or private sale
|
Direct |
70,000
-51.17%
|
$2,940,000
$42.28 P/Share
|
|
Nov 16
2020
|
Douglas M Van Oort Director |
SELL
Open market or private sale
|
Direct |
100,000
-3.96%
|
$4,200,000
$42.34 P/Share
|
|
Nov 16
2020
|
Douglas M Van Oort Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.79%
|
$140,000
$7.52 P/Share
|
|
Nov 13
2020
|
Douglas M Van Oort Director |
SELL
Open market or private sale
|
Direct |
118,752
-4.53%
|
$4,868,832
$41.56 P/Share
|
|
Nov 13
2020
|
Douglas M Van Oort Director |
BUY
Exercise of conversion of derivative security
|
Direct |
358,752
+12.04%
|
$2,511,264
$7.52 P/Share
|
|
Nov 12
2020
|
Douglas M Van Oort Director |
SELL
Open market or private sale
|
Direct |
121,248
-5.09%
|
$5,092,416
$42.18 P/Share
|
|
Nov 12
2020
|
Douglas M Van Oort Director |
BUY
Exercise of conversion of derivative security
|
Direct |
121,248
+4.84%
|
$848,736
$7.52 P/Share
|
|
Nov 10
2020
|
Denise E Pedulla General Counsel |
SELL
Open market or private sale
|
Direct |
2,262
-3.83%
|
$95,004
$42.0 P/Share
|
|
Nov 10
2020
|
Denise E Pedulla General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+20.27%
|
$105,000
$7.85 P/Share
|